casimersen
Marketedupdated 2mo agoby $SRPT Sarepta Therapeutics, Inc.
Approvedcommunity read0 votes
Oligonucleotide drug with a maximum clinical stage of Approval (across all indications), with an approval for duchenne muscular dystrophy and muscular dystrophy.
indications
investigational
Duchenne Muscular Dystrophy
all catalysts(4)
approval · 4
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that